Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This comparison answers which has lower fees between SP 500 ETF and index fund in 2024, with practical tips to minimize costs.
28,240 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As a NATO summit approaches this week in Turkey, Trump shifts the debate from defense spending to loyalty, challengin...
SpaceX stock has pulled back after a brisk IPO run, trading in the low to mid 140s as of today. This report breaks do...
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
Adobe sits as a candidate undervalued stock that could rebound in 2026, trading in the low-$280s with a 16x trailing ...
Micron Technology expands in Taiwan by acquiring Powerchip's P5 site, boosting DRAM and HBM capacity and setting up a...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
Legendary investor Paul Tudor Jones warns that the Trump-era market boom could end in a 30-35% correction, even as he...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...
A Google software engineer is facing insider trading charges after allegedly using confidential internal data to prof...
NVIDIA led the AI hardware rally, but the backbone of today’s AI deployments sits in memory and storage. This piece e...
ICE joins Anthropic’s Project Glasswing to deploy Claude Mythos Preview across its markets, aiming to identify vulner...